BorgWarner's Analyst Upgrades Clash With a Stock Down 10% in a Month
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
BWA reports Q3 results on October 29 against a backdrop of sharply diverging signals: Wall Street's most influential names have turned decisively bullish in the past few weeks, while the shares have lost 10% in the past month and options traders shifted abruptly more defensive on Friday.
The options move is the sharpest near-term signal. The put/call ratio jumped to 0.35 on October 23, more than three standard deviations above its 20-day average of 0.31. That is the largest deviation of the past year by this measure, suggesting a single session of heavy put buying ahead of the print. The broader borrow market tells a different story: short interest has eased about 9% over the past month to roughly 3.2% of the free float, borrowing costs have more than halved to 0.24%, and availability is extremely loose with more than 50 shares available for every one currently borrowed. There is no meaningful squeeze risk in the lending market.
The analyst picture is the most interesting development in recent weeks. Morgan Stanley upgraded BWA to Overweight on October 6, lifting its target from $71 to $95, and Bank of America followed on October 15 with an upgrade from Neutral to Buy at an $85 target. The consensus mean across the coverage universe is $81.27, implying roughly 48% upside to the current price of $54.96. That gap between where analysts think the stock should trade and where it actually trades is the central tension heading into the print. JPMorgan and Barclays both carry Overweight ratings with targets in the mid-$80s, while TD Cowen holds at Hold with a $68 target, the main dissenting voice.
The stock's own recent earnings history lends some support to the optimistic camp. The August 2026 print produced a 4.4% single-day gain and the shares added another 9.2% over the five days that followed. The prior Q1 report generated a smaller 2.5% one-day move and a 5.8% five-day follow-through. In both cases, the stock gained. At the same time, peers have broadly weakened: closest correlated names VC fell more than 12% on the week and APTV dropped nearly 5%, so BWA's 5.5% weekly decline is roughly in line with the group rather than a company-specific selloff.
The print will test whether BorgWarner's operational progress is sufficient to close the distance between a $55 stock and an analyst community with targets averaging nearly $30 higher.
Stocks in this article
See the live data behind this article on ORTEX.
Open BWA on ORTEX →How this article was generated
- Generated
- 26 Oct 2026, 04:05
- Data as of
- 26 Oct 2026, 04:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.